Patient care for SUD, mental illness, chronic pain during COVID-19
2元彩票The AMA provides guidance on caring for patients with substance use disorder, mental illness or chronic pain during the COVID-19 pandemic.
COVID-19 policy recommendations for OUD, pain, harm reduction
The AMA provides policy recommendations to help guide policymakers reduce the stress of patients with an opioid use disorder and pain during the COVID-19 outbreak.
Helping private practices navigate non-essential care during COVID-19
2元彩票Private practice physicians are currently facing new and unfamiliar challenges in safely delivering care to non-urgent patients.
AMA recommends exceptions to facilitate opioid use disorder treatment
The blanket exception will allow patients to obtain up to 28 days of take-home medication if they are stable and up to 14 days for patients who are less stable.
New York effort raises use of MAT for opioid-use disorder
Medications for addiction treatment (MAT) are underused, with racial, geographic and economic barriers. Learn about a Big Apple initiative that’s making big changes.
After his son’s death, Massachusetts physician seeks to help others
2元彩票James Baker, MD, whose son died of an overdose at 23, provides phone support to primary care doctors treating patients with substance-use disorders.
AMA in the News
AMA in the News: February 2020
2元彩票Read media highlights mentioning the American Medical Association for February 2020.
End the epidemic
AMA membership means you’re actively fighting to end the opioid crisis. Help us build a strong, nationwide program of comprehensive pain care to help reverse this epidemic.
News from the AMA
Get the latest news delivered to your inbox from one of our popular e-mail publications, tailored to meet your informational needs.
Essential Tools & Resources
AMA member physicians get a 35% discount on own-specialty disability insurance premiums.